Miravirsen (SPC-3649) is a potent miR-122 inhibitor and inhibits the biogenesis of miR-122. Miravirsen is a 15-nucleotide locked nucleic acid-modified phosphorothioate antisense oligonucleotide. Miravirsen inhibits HCV replication. Miravirsen can be used in research of HCV infection In Vitro Miravirsen is thought to work mainly by hybridizing to mature miR-122 and blocking its interaction with HCV RNA, its target sequence is also present in pri- and pre-miR-122. Miravirsen binds to the stem-loop structure of pri- and pre-miR-122 with nanomolar affinity, and inhibits both Dicer- and Drosha-mediated processing of miR-122 precursors. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Miravirsen (SPC-3649; 2.5-25 mg/kg; i.v.; daily, for 3 d) inhibits miR-122 activity in mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: NMRI female mice (27 g)Dosage: 2.5, 6.25, 12.5, and 25 mg/kg Administration: Intravenous injection; daily, for 3 days Result: Inhibited miR-122 activity in a dose-dependent manner. Form:Solid IC50& Target:miR-122
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Miravirsen
CAS number：1072874-90-8 molecular formula：
overview
compound introduction
Specs
| Chinese alias | 米拉韦森 | ||
| English alias | - | ||
| CAS number | 1072874-90-8 | molecular formula | |
| molecular weight | 4967.00 g/mol | Exact mass | ≥98% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
